Several interconnecting barriers continue to hinder PrEP access and exacerbate HIV prevention disparities.

Detailed phase 3 results suggest the two-drug combination of Gilead Sciences’ lenacapavir and Merck & Co.’s islatravir has ...

The US Food and Drug Administration's (FDA) drug regulatory division announced the approval of a new indication for Gilead's Truvada (emtricitabine/tenofovir disoproxil fumarate), making it the first ...

Since the start of the HIV epidemic in 1981, over 700,000 Americans have lost their lives to AIDS. Being infected used to be a death sentence. But now, 40 years later, the U.S. is on the precipice of ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) for Yeztugo® (lenacapavir) 300-mg tablet as a ...

California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday. The pill, which is already used to treat HIV patients, will be ...

Kegoratile Aphane did not flinch when the needle pierced the skin of her right buttock, injecting a yellow-colored drug touted as a revolution that could end the HIV pandemic. The 32-year-old was ...

HARARE, Feb 19 (Reuters) - Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making ‌the country one of the first globally to roll it ‌out ...

Patrick Chakwana, 50, has lived with HIV since 1999, when there was no effective treatment and the message to those diagnosed ...

Amidst the presentations at the 2012 International AIDS Conference in Washington, D.C., a new drug called Truvada was a conversation lightning rod. The pill, which has been proven to decrease the ...

You can now live a long and healthy life with HIV, thanks largely to medication that has turned it from a fatal infection and terminal illness into a chronic but manageable condition. Antiretroviral ...